Michael Wolf
ORCID: 0000-0003-0259-9945
· 1 paper in corpus
ObjectiveTo establish the use of aromatase inhibitors as a therapeutic option for endometriosis.DesignProspective open-label Food and Drug Administration phase 2 trial with Institutional Review Board approval.SettingOutpatient tertiary care…